A Prospective, Multicenter, Open-Label, Single-Arm Study of the Safety and Tolerability of a Single, Intravitreal Injection of Human Retinal Progenitor Cells (jCell) in Adult Subjects With Retinitis Pigmentosa (RP)
Phase of Trial: Phase I/II
Latest Information Update: 21 Aug 2017
At a glance
- Drugs Retinal stem cell therapy jCyte (Primary)
- Indications Retinitis pigmentosa
- Focus Adverse reactions
- Sponsors jCyte
- 15 Aug 2017 Status changed from active, no longer recruiting to completed.
- 15 Dec 2016 Planned primary completion date changed from 1 Dec 2016 to 1 Jul 2017.
- 15 Dec 2016 Status changed from recruiting to active, no longer recruiting.